TCP
ZBH icon

Tourbillon Capital Partners’s Zimmer Biomet ZBH Stock Holding History

Tourbillon Capital Partners’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-103,000
Closed -$12.8M – 76
2017
Q2 		$12.8M Buy
+103,000
New +$12.2M 0.25% 57
2017
Q1 		– Sell
-321,875
Closed -$32.3M – 77
2016
Q4 		$32.3M Buy
+321,875
New +$34.5M 0.62% 41

Other funds holding ZBH

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return
JP
Jana Partners New York $1.34B AUM 4.95% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Tourbillon Capital Partners's ZBH Position: Q3 2017 in Review

Tourbillon Capital Partners sold out of Zimmer Biomet (ZBH) in Q3 2017, closing a stake of 103,000 shares — an estimated $12.8M sold.

Tourbillon Capital Partners first reported a position in ZBH in Q4 2016 and held it in 2 quarters. The position peaked at $32.3M in Q4 2016. 818 funds tracked by Wall St. Rank hold ZBH as of Q3 2017.

  • Tourbillon Capital Partners reported no remaining Zimmer Biomet position as of Q3 2017 after selling out during the quarter.
  • Tourbillon Capital Partners sold 103,000 Zimmer Biomet shares in Q3 2017, an estimated $12.8M.
  • Tourbillon Capital Partners first reported a position in Zimmer Biomet in Q4 2016 and held it in 2 quarters.
  • Tourbillon Capital Partners's Zimmer Biomet position peaked at $32.3M in Q4 2016.
  • 818 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2017.

Based on Tourbillon Capital Partners's 13F filing for Q3 2017, filed 14 Nov 2017.